Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Incyte (INCY) -- Ignore unavailable to you. Want to Upgrade?

To: Cytokine1 who wrote (534)	12/10/1997 9:49:00 PM
From: dbuki	Read Replies (1) \| Respond to of 3202

I remember having come across last week comments made by R. Whitfield, Pres. and CEO, at the Robertson Stephens biotech conference. He stated that 1998 (and 1999?)revenues would at least be equal to this year's. Probably was considered to be below expectations. The stock took a hit next day. He also stated that the company is working on some new database products. Sorry that I can only paraphrase and did not save the link.

To: Cytokine1 who wrote (534)	12/11/1997 10:23:00 AM
From: James Hutton	Read Replies (1) \| Respond to of 3202

Thanks for the information. I was referring to projected PE at a Price in the low-mid 40s. But anyhow, I'm still going to hold on till this current wave of volatility goes by. I think any price in or below the low 30s would be attractive. Re ANLT, I'd hold off. I love the company but the stock has gotten a little pricey. My target for the end of 98 is 38-40, so anything in the mid-20s would be a good entry point, in my opinion. Good luck. Jon